Browsing by Author Diana M. Gibb

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
1-Jan-2013Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected childrenLinda Harrison; Jintanat Ananworanich; Djamel Hamadache; Alexandra Compagnucci; Martina Penazzato; Torsak Bunupuradah; Antonio Mazza; Jose Tomas Ramos; Jacquie Flynn; Osvalda Rampon; Maria Jose Mellado Pena; Daniel Floret; Magdalena Marczynska; Ana Puga; Silvia Forcat; Yoann Riault; Marc Lallemant; Hannah Castro; Diana M. Gibb; Carlo Giaquinto
20-Feb-2022Borrowing information across patient subgroups in clinical trials, with application to a paediatric trialRebecca M. Turner; Anna Turkova; Cecilia L. Moore; Alasdair Bamford; Moherndran Archary; Linda N. Barlow-Mosha; Mark F. Cotton; Tim R. Cressey; Elizabeth Kaudha; Abbas Lugemwa; Hermione Lyall; Hilda A. Mujuru; Veronica Mulenga; Victor Musiime; Pablo Rojo; Gareth Tudor-Williams; Steven B. Welch; Diana M. Gibb; Deborah Ford; Ian R. White
30-Dec-2021Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in ChildrenAnna Turkova; Ellen White; Hilda A. Mujuru; Adeodata R. Kekitiinwa; Cissy M. Kityo; Avy Violari; Abbas Lugemwa; Tim R. Cressey; Philippa Musoke; Ebrahim Variava; Mark F. Cotton; Moherndran Archary; Thanyawee Puthanakit; Osee Behuhuma; Robin Kobbe; Steven B. Welch; Mutsa Bwakura-Dangarembizi; Pauline Amuge; Elizabeth Kaudha; Linda Barlow-Mosha; Shafic Makumbi; Nastassja Ramsagar; Chaiwat Ngampiyaskul; Godfrey Musoro; Lorna Atwine; Afaaf Liberty; Victor Musiime; Dickson Bbuye; Grace M. Ahimbisibwe; Suwalai Chalermpantmetagul; Shabinah Ali; Tatiana Sarfati; Ben Wynne; Clare Shakeshaft; Angela Colbers; Nigel Klein; Sarah Bernays; Yacine Saïdi; Alexandra Coelho; Tiziana Grossele; Alexandra Compagnucci; Carlo Giaquinto; Pablo Rojo; Deborah Ford; Diana M. Gibb
1-Dec-2021ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosingCecilia L. Moore; Anna Turkova; Hilda Mujuru; Adeodata Kekitiinwa; Abbas Lugemwa; Cissy M. Kityo; Linda N. Barlow-Mosha; Tim R. Cressey; Avy Violari; Ebrahim Variava; Mark F. Cotton; Moherndran Archary; Alexandra Compagnucci; Thanyawee Puthanakit; Osee Behuhuma; Yacine Saϊdi; James Hakim; Pauline Amuge; Lorna Atwine; Victor Musiime; David M. Burger; Clare Shakeshaft; Carlo Giaquinto; Pablo Rojo; Diana M. Gibb; Deborah Ford; Shabinah Ali; Abdel Babiker; Chiara Borg; Anne Marie Borges Da Silva; Joanna Calvert; Joshua Gasa; Nasir Jamil; Sarah Lensen; Emma Little; Fatima Mohamed; Samuel Montero; Cecilia L. Moore; Rachel Oguntimehin; Anna Parker; Reena Patel; Tasmin Phillips; Tatiana Sarfati; Karen Scott; Moira Spyer; Margaret Thomason; Rebecca Turner; Nadine Van Looy; Ellen White; Kaya Widuch; Helen Wilkes; Ben Wynne; Tiziana Grossele; Daniel Gomez-Pena; Davide Bilardi; Giulio Vecchia; Yacine Saidi; Yoann Riault; Alexandra Coelho; Laura Picault; Christelle Kouakam; Suwalai Chalermpantmetagul; Dujrudee Chinwong; Gonzague Jourdain; Rukchanok Peongjakta; Pra ornsuda Sukrakanchana; Wasna Sirirungsi; Janet Seeley; Sarah Bernays; Magda Conway; Nigel Klein; Eleni Nastouli; Anita De Rossi; Maria Angeles Munoz Fernandez; David Burger; Pauline Bollen; Angela Colbers; Hylke Waalewijn; Elizabeth Kaudha; Annet Nanduudu; Emmanuel Mujyambere; Paul Ocitti Labeja; Charity Nankunda; Juliet Ategeka; Peter Erim; Collin Makanga; Esther Nambi; Edridah Keminyeto; Deogratiuos Tukwasibwe; Shafic Makumbi; Emily Ninsiima; Mercy Tukamushaba; Rogers Ankunda; Ian Natuhurira; Miriam Kasozi; Baker Rubinga; Adeodata R. Kekitiinwa; Dickson Bbuye; Justine Nalubwama; Winnie Akobye
15-Aug-2018Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIVDeborah Ford; Rebecca Turner; Anna Turkova; Martina Penazzato; Victor Musiime; Mutsa Bwakura-Dangarembizi; Avy Violari; Chishala Chabala; Thanyawee Puthanakit; Tavitiya Sudjaritruk; Tim R. Cressey; Marc Lallemant; Diana M. Gibb
15-May-2008Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected childrenTim R. Cressey; Hannah Green; Saye Khoo; Jean Marc Treluyer; Alexandra Compagnucci; Yacine Saidi; Marc Lallemant; Diana M. Gibb; David M. Burger
1-Apr-2018Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trialAnna Turkova; Cecilia L. Moore; Karina Butler; Alexandra Compagnucci; Yacine Saïdi; Victor Musiime; Annet Nanduudu; Elizabeth Kaudha; Tim R. Cressey; Suwalai Chalermpantmetagul; Karen Scott; Lynda Harper; Samuel Montero; Yoann Riault; Torsak Bunupuradah; Alla Volokha; Patricia M. Flynn; Rosa Bologna; Jose T. Ramos Amador; Steven B. Welch; Eleni Nastouli; Nigel Klein; Carlo Giaquinto; Deborah Ford; Abdel Babiker; Diana M. Gibb